Tue, Sep 16, 2014, 1:54 AM EDT - U.S. Markets open in 7 hrs 36 mins

Recent

% | $
Quotes you view appear here for quick access.

Cytosorbents Corporation Message Board

  • berthabluefish berthabluefish Jul 16, 2013 8:25 AM Flag

    Cytokines in Sepsis

    New on PubMed.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Must really be a good write up on ctso?

      • 1 Reply to cruizon
      • Went to pubmed. Nothing on sepsis and cytosorb filter. This abstract reads like ancient history and all the failed therapies. Sounds like best treatment for sepsis is prayer, as it has been for years. So my issue with this is how CTSO has been approved for 2.5 years, numerous conferences and opportunities to sell the filter and we can't get mentioned in a current assesment of sepsis. What's wrong with this picture. Maybe pings newsletter news will lead to something??

    • Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets-An Updated View.
      Schulte W, Bernhagen J, Bucala R.
      Source
      Department of Internal Medicine, Yale University School of Medicine, The Anlyan Center, S525, P.O. Box 208031, 300 Cedar Street, New Haven, CT 06520-8031, USA ; Institute of Biochemistry and Molecular Cell Biology, University Hospital of RWTH Aachen University, Pauwelsstraße 30, 52074 Aachen, Germany.
      Abstract
      Sepsis and septic shock are among the leading causes of death in intensive care units worldwide. Numerous studies on their pathophysiology have revealed an imbalance in the inflammatory network leading to tissue damage, organ failure, and ultimately, death. Cytokines are important pleiotropic regulators of the immune response, which have a crucial role in the complex pathophysiology underlying sepsis. They have both pro- and anti-inflammatory functions and are capable of coordinating effective defense mechanisms against invading pathogens. On the other hand, cytokines may dysregulate the immune response and promote tissue-damaging inflammation. In this review, we address the current knowledge of the actions of pro- and anti-inflammatory cytokines in sepsis pathophysiology as well as how these cytokines and other important immunomodulating agents may be therapeutically targeted to improve the clinical outcome of sepsis.

 
CTSO
0.24+0.01(+3.00%)Sep 15 3:58 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
21Vianet Group, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
JDS Uniphase Corporation
NasdaqGSMon, Sep 15, 2014 4:15 PM EDT